$6.34 Million is the total value of Copernicus Capital Management, LLC's 11 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 121.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $1,815,000 | +181.4% | 9,000 | +200.0% | 28.62% | +174.6% |
| FATE | Buy | FATE THERAPEUTICS INC | $868,000 | +31.5% | 10,000 | +25.0% | 13.69% | +28.4% |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $778,000 | – | 50,000 | +100.0% | 12.27% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $532,000 | – | 10,000 | +100.0% | 8.39% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $492,000 | – | 30,000 | +100.0% | 7.76% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $468,000 | – | 5,000 | +100.0% | 7.38% | – |
| ACCD | New | ACCOLADE INC | $380,000 | – | 7,000 | +100.0% | 5.99% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $355,000 | – | 2,000 | +100.0% | 5.60% | – |
| GRTS | Sell | GRITSTONE BIO INC | $320,000 | -8.3% | 35,000 | -5.4% | 5.05% | -10.5% |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $168,000 | – | 10,000 | +100.0% | 2.65% | – |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $165,000 | -41.3% | 20,000 | +100.0% | 2.60% | -42.7% |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCads | $0 | – | -15,000 | -100.0% | -1.76% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -1,500 | -100.0% | -4.41% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -18,000 | -100.0% | -4.46% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -50,000 | -100.0% | -5.35% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -7,000 | -100.0% | -5.44% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -8,000 | -100.0% | -5.74% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -10,000 | -100.0% | -7.42% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -6,000 | -100.0% | -10.49% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -1,500 | -100.0% | -11.47% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -10,000 | -100.0% | -12.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.